Managing the ocular surface after glaucoma filtration surgery: an orphan topic

L Agnifili, M Figus, M Sacchi, F Oddone… - Graefe's Archive for …, 2024 - Springer
Background Ocular surface (OS) disorders before glaucoma filtration surgery (GFS) have
been considered to play a crucial role influencing the surgical outcome. Conversely, the …

Preserflo MicroShunt Implantation: A Narrative Review of Its Standalone Benefits vs. Combined Use with Phacoemulsification in Managing Open-Angle Glaucoma

M Chilmonczyk, K Gołaszewska, E Saeed… - Ophthalmology and …, 2024 - Springer
Glaucoma and cataract often coexist. Patients with both conditions who qualify for surgical
treatment may undergo either a combined surgical procedure or sequential treatments such …

Risk Factors for Failure in Glaucoma Patients Undergoing Microshunt Implantation

A Rabiolo, R Toscani, M Sacchi, P Destefanis… - American Journal of …, 2024 - Elsevier
PURPOSE To evaluate risk factors for failure of Microshunt in glaucoma patients. DESIGN
Multicenter retrospective cohort study. METHODS The study included 220 eyes from 220 …

All consecutive ab externo SIBS Microshunt implantations with mitomycin C: one-year outcomes and risk factors for failure

MB Schlenker, JJ Armstrong, T De Francesco… - American Journal of …, 2023 - Elsevier
PURPOSE To present the effectiveness, risk factors for surgical failure, and adverse events
over 12 months in a consecutive diverse cohort of glaucoma patients who underwent solo or …

Safety and efficacy of ab interno XEN 45 gel stent in patients with glaucoma and high myopia

M Sacchi, AM Fea, G Monsellato, E Tagliabue… - Journal of Clinical …, 2023 - mdpi.com
This study reports on the safety and efficacy of Xen 45 in patients with glaucoma and high
myopia. It was a retrospective study including patients with high myopia (> 6D) who …

Intravitreal bevacizumab improves trabeculectomy survival at 12 months: the bevacizumab in trabeculectomy study—a randomised clinical trial

JA Landers, S Mullany, JE Craig - British Journal of Ophthalmology, 2024 - bjo.bmj.com
Aims To evaluate the effect of an intraoperative dose of intravitreal bevacizumab (Avastin)
on surgical success following trabeculectomy with mitomycin-C (MMC) over 12 months …

Comparison of 5-year outcomes between trabeculectomy combined with phacoemulsification and trabeculectomy followed by phacoemulsification: a retrospective …

S Arimura, K Iwasaki, Y Orii, Y Takamura, M Inatani - BMC ophthalmology, 2021 - Springer
Background We aimed to compare the outcomes of trabeculectomy combined with
phacoemulsification and those of trabeculectomy followed by phacoemulsification. Methods …

Ocular surface and glaucoma, a mutual relationship. Practical suggestions for classification and management

M Figus, M Sacchi, GC Rossi… - European Journal …, 2023 - journals.sagepub.com
The chronic use of glaucoma medications could improve the development of an ocular
comorbidity, the glaucoma therapy-related ocular surface disease. This could be related to …

Phacoemulsification versus Phacoemulsification/Trabeculectomy for the Treatment of Primary Open-Angle Glaucoma Coexistent with Cataract: A Comparative Study

A Kaliardas, I Chatziralli, A Katsanos, G Kitsos - Medicina, 2023 - mdpi.com
Background: The purpose of this study was to evaluate the clinical outcomes in patients with
primary open-angle glaucoma (POAG) and coexistent cataract treated with …

Short-term outcomes of Mitomycin-C augmented phaco-trabeculectomy using subconjunctival injections versus soaked sponges: a randomized controlled trial

S Chakrabarty, MA Kader, D Maheshwari, MR Pillai… - Eye, 2024 - nature.com
Objectives To determine whether subconjunctival Mitomycin-C (MMC) injections are as safe
and effective as sponge-soaked MMC in phaco-trabeculectomy. Methods This prospective …